A critical advance in cancer study is occurring with the use of mini-antibodies to re-engage damaged p53. This essential tumor inhibitor protein is frequently disabled in several types of tumors, resulting uncontrolled https://bookmarksurl.com/story7638065/mini-antibodies-restore-tumor-suppressor-p53-the-promising-hope-for-malignant-therapy